261 related articles for article (PubMed ID: 27681573)
1. Candida glabrata species complex prevalence and antifungal susceptibility testing in a culture collection: First description of Candida nivariensis in Argentina.
Morales-López SE; Taverna CG; Bosco-Borgeat ME; Maldonado I; Vivot W; Szusz W; Garcia-Effron G; Córdoba SB
Mycopathologia; 2016 Dec; 181(11-12):871-878. PubMed ID: 27681573
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species,
Sikora M; Kuthan R; Piskorska-Malolepsza K; Golas-Pradzynska M; Domański D; Augustynowicz-Kopeć E; Swoboda-Kopec E
Pol J Microbiol; 2019 Sep; 68(3):303-308. PubMed ID: 31880875
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization and antifungal susceptibility testing of Candida nivariensis from blood samples - an Iranian multicentre study and a review of the literature.
Arastehfar A; Daneshnia F; Salehi MR; Zarrinfar H; Khodavaisy S; Haas PJ; Roudbary M; Najafzadeh MJ; Zomorodian K; Charsizadeh A; Brouwer C; Pan W; Hagen F; Boekhout T
J Med Microbiol; 2019 May; 68(5):770-777. PubMed ID: 30924763
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.
Miranda-Zapico I; Eraso E; Hernández-Almaraz JL; López-Soria LM; Carrillo-Muñoz AJ; Hernández-Molina JM; Quindós G
J Antimicrob Chemother; 2011 Oct; 66(10):2315-22. PubMed ID: 21795259
[TBL] [Abstract][Full Text] [Related]
5. Occurrence and characterization of Candida nivariensis from a culture collection of Candida glabrata clinical isolates in Malaysia.
Tay ST; Lotfalikhani A; Sabet NS; Ponnampalavanar S; Sulaiman S; Na SL; Ng KP
Mycopathologia; 2014 Oct; 178(3-4):307-14. PubMed ID: 25022264
[TBL] [Abstract][Full Text] [Related]
6. MALDI-TOF typing highlights geographical and fluconazole resistance clusters in Candida glabrata.
Dhieb C; Normand AC; Al-Yasiri M; Chaker E; El Euch D; Vranckx K; Hendrickx M; Sadfi N; Piarroux R; Ranque S
Med Mycol; 2015 Jun; 53(5):462-9. PubMed ID: 25841053
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic and Molecular Evaluation of Echinocandin Susceptibility of Candida glabrata, Candida bracarensis, and Candida nivariensis Strains Isolated during 30 Years in Argentina.
Morales-López S; Dudiuk C; Vivot W; Szusz W; Córdoba SB; Garcia-Effron G
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461313
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and antifungal susceptibility profiles of Candida glabrata, Candida parapsilosis and their close-related species in oral candidiasis.
Miranda-Cadena K; Marcos-Arias C; Mateo E; Aguirre JM; Quindós G; Eraso E
Arch Oral Biol; 2018 Nov; 95():100-107. PubMed ID: 30096698
[TBL] [Abstract][Full Text] [Related]
9. Clinical Characteristics and Antifungal Susceptibility of Candida nivariensis from Vulvovaginal Candidiasis.
Shi Y; Zhu Y; Fan S; Vitagliano A; Liu X; Liao Y; Liang Y; Vitale SG
Gynecol Obstet Invest; 2020; 85(1):88-93. PubMed ID: 31694024
[TBL] [Abstract][Full Text] [Related]
10. Identification and Antifungal Susceptibility Profiles of
Hou X; Xiao M; Chen SC; Wang H; Yu SY; Fan X; Kong F; Xu YC
Front Microbiol; 2017; 8():5. PubMed ID: 28154553
[No Abstract] [Full Text] [Related]
11. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of human pathogens of the clade Nakaseomyces in a culture collection-the first report on Candida bracarensis in Poland.
Małek M; Mrowiec P; Klesiewicz K; Skiba-Kurek I; Szczepański A; Białecka J; Żak I; Bogusz B; Kędzierska J; Budak A; Karczewska E
Folia Microbiol (Praha); 2019 May; 64(3):307-312. PubMed ID: 30361876
[TBL] [Abstract][Full Text] [Related]
13. Anidulafungin Susceptibility Testing of Candida glabrata Isolates from Blood Cultures by the MALDI Biotyper Antibiotic (Antifungal) Susceptibility Test Rapid Assay.
Vatanshenassan M; Arastehfar A; Boekhout T; Berman J; Lass-Flörl C; Sparbier K; Kostrzewa M
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285227
[TBL] [Abstract][Full Text] [Related]
14. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
15. Identification of Candida glabrata complex species: use of Vitek MS
Hou X; Xiao M; Chen SC; Kong F; Wang H; Fan X; Zhao YP; Xu YC
Future Microbiol; 2018 May; 13():645-657. PubMed ID: 29745727
[TBL] [Abstract][Full Text] [Related]
16. First Isolation of Candida nivariensis, an Emerging Fungal Pathogen, in Kuwait.
Alobaid K; Asadzadeh M; Bafna R; Ahmad S
Med Princ Pract; 2021; 30(1):80-84. PubMed ID: 32927454
[TBL] [Abstract][Full Text] [Related]
17. Lack of detection of Candida nivariensis and Candida bracarensis among 440 clinical Candida glabrata sensu lato isolates in Kuwait.
Asadzadeh M; Alanazi AF; Ahmad S; Al-Sweih N; Khan Z
PLoS One; 2019; 14(10):e0223920. PubMed ID: 31618264
[TBL] [Abstract][Full Text] [Related]
18. Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents.
Borman AM; Petch R; Linton CJ; Palmer MD; Bridge PD; Johnson EM
J Clin Microbiol; 2008 Mar; 46(3):933-8. PubMed ID: 18199788
[TBL] [Abstract][Full Text] [Related]
19. Caenorhabditis elegans as a Model System To Assess Candida glabrata,
Hernando-Ortiz A; Mateo E; Ortega-Riveros M; De-la-Pinta I; Quindós G; Eraso E
Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32718968
[TBL] [Abstract][Full Text] [Related]
20. In vitro fungicidal activities of anidulafungin, caspofungin, and micafungin against Candida glabrata, Candida bracarensis, and Candida nivariensis evaluated by time-kill studies.
Gil-Alonso S; Jauregizar N; Cantón E; Eraso E; Quindós G
Antimicrob Agents Chemother; 2015; 59(6):3615-8. PubMed ID: 25801575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
